A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP)

Girouard, N., Johnson, L., Luecke, E., Demkovich, Z., Jester, T., Li, A., Johnson, P., & van der Straten, A. (2018). A subcutaneous biodegradable implant for sustained delivery of tenofovir alafenamide (TAF) for HIV pre-exposure prophylaxis (PrEP). AIDS Research and Human Retroviruses, 34, 107.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Epigenetic biomarkers for smoking cessation
Article

A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood
Article

The effects of exposure to road traffic noise at school on central auditory pathway functional connectivity